No standard of care is established for plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemotherapy and display resistance to commonly applied cytostatic drugs.
Broccoli, A., Nanni, L., Stefoni, V., Agostinelli, C., Argnani, L., Cavo, M., et al. (2018). A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report. BMC CANCER, 18(1), 1-5 [10.1186/s12885-018-4561-9].
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report
Broccoli, Alessandro;Nanni, Laura;Stefoni, Vittorio;Agostinelli, Claudio;Argnani, Lisa;Cavo, Michele;Zinzani, Pier Luigi
2018
Abstract
No standard of care is established for plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemotherapy and display resistance to commonly applied cytostatic drugs.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s12885-018-4561-9.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
1.34 MB
Formato
Adobe PDF
|
1.34 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
